A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(8 sites)

China

Fujian Cancer Hospital, Fuzhou, Fujian

Henan Cancer Hospital, Zhengzhou, Henan

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei

Caixia Liu, Hohhot, Inner Mongolia

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality

Shanxi Cancer Hospital, Shanxi, Taiyuan

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Peking union medical college hospital, Beijing